Related Experiment Video
Updated: Jul 1, 2025

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
Published on: October 16, 2021
Mitral Regurgitation Complicated by Cardiogenic Shock: Reassessing Risk Stratification and Therapeutic Strategies
Carla Boyle1, Khoa Nguyen1, Johannes Steiner1
1Division of Cardiology, Knight Cardiovascular Institute, Oregon Health & Science University, 3161 Southwest Pavilion Loop, Portland, OR 97239, USA.
Mitral regurgitation with cardiogenic shock requires advanced support and definitive treatments like valve surgery or trans-catheter repair. This review guides clinicians through management options and emerging technologies for better patient outcomes.
Area of Science:
- Cardiology
- Cardiovascular Surgery
- Interventional Cardiology
Background:
- Mitral regurgitation (MR) combined with cardiogenic shock presents a severe clinical challenge.
- Limited effective management strategies exist for this complex patient population.
Purpose of the Study:
- To review current evidence for supportive and definitive management strategies for MR complicated by cardiogenic shock.
- To provide a clinical decision-making framework for healthcare providers.
- To discuss emerging transcatheter mitral valve replacement technologies.
Main Methods:
- Comprehensive literature review of supportive measures (vasodilators, mechanical circulatory support) and definitive treatments (surgical, transcatheter).
- Evaluation of existing evidence for efficacy and patient outcomes.
- Analysis of emerging transcatheter mitral valve replacement (TMVR) technologies.
Main Results:
- Supportive measures are crucial for hemodynamic stabilization before definitive intervention.
- Both surgical mitral valve replacement and trans-catheter edge-to-edge repair are established definitive treatments.
- Emerging TMVR technologies show potential for improved outcomes in select patients.
Conclusions:
- A structured approach is needed to manage MR with cardiogenic shock.
- Mechanical circulatory support and timely definitive valve intervention are key.
- Advancements in transcatheter therapies offer future hope for this high-risk group.
More Related Videos
07:42An Image Guided Transapical Mitral Valve Leaflet Puncture Model of Controlled Volume Overload from Mitral Regurgitation in the Rat
Published on: May 19, 2020
08:42Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
Published on: February 11, 2022
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Pathophysiology of Heart Failure